Skip to content

Targeted Oncology:

Biologically Validated. Chemistry Enabled. Albumin Protected.

Exploiting metabolic pathways to target tumors with effective therapeutics.

Our initial development programs are focused on oncology, specifically related to therapeutics.

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit

About Us

Our Product Strategy

January Therapeutics is targeting cell-essential drivers of cancer which cannot be successfully drugged by chemistry alone. January’s technology exploits the dysregulated metabolic pathways in cancer and uses albumin to preferentially deliver drug to tumors while sparing healthy cells.

Sam Ellis

CEO

News and Events

Some recent milestones

Contact

Get in touch

11575 Sorrento Valley Road, Suite 212
San Diego, California 92121

Lorem ipsum

consectetur adipiscing elit

John Smith

Sample Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod te mpor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus vel fa cilisis commodo viverra.